The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis

The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: a meta-analysis

(2013) Xiao-Ling Xu et al.   BREAST CANCER RESEARCH AND TREATMENT

Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer

(2012) Niels Fristrup et al.   AMERICAN JOURNAL OF PATHOLOGY

Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: Systematic review and meta-analysis

(2012) James W. Rainsbury et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Clinicopathological and prognostic role of cyclin D1 in esophageal squamous cell carcinoma: a meta-analysis

(2011) J. Zhao et al.   DISEASES OF THE ESOPHAGUS

A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers

(2011) Siwanon Jirawatnotai et al.   NATURE

D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance

(2010) Georgia Levidou et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Expression of pRb, p53, p16 and Cyclin D1 and Their Clinical Implications in Urothelial Carcinoma

(2010) Kyungji Lee et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

p53 expression in patients with advanced urothelial cancer of the urinary bladder

(2009) Shahrokh F. Shariat et al.   BJU INTERNATIONAL

Expression of cell cycle-associated proteins in non-muscle-invasive bladder cancer: Correlation with intravesical recurrence following transurethral resection

(2009) Hosny M. Behnsawy et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

The present and future burden of urinary bladder cancer in the world

(2009) Martine Ploeg et al.   WORLD JOURNAL OF UROLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE